A61K 31/085
Having an ether linkage to aromatic ring nuclear carbon
Official title: having an ether linkage to aromatic ring nuclear carbon
A61K31/085 (Having an ether linkage to aromatic ring nuclear carbon) appears on 845 US grants and 1,560 published applications in this corpus.
Search patents in A61K- Granted patents
- 845
- Published applications
- 1,560
- Assignees
- 792
- Inventors
- 2,999
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 12 | 0 |
| 1998 | 4 | 0 |
| 1999 | 13 | 0 |
| 2000 | 7 | 0 |
| 2001 | 18 | 6 |
| 2002 | 11 | 30 |
| 2003 | 13 | 47 |
| 2004 | 12 | 36 |
| 2005 | 9 | 42 |
| 2006 | 10 | 26 |
| 2007 | 5 | 23 |
| 2008 | 4 | 38 |
| 2009 | 4 | 57 |
| 2010 | 11 | 47 |
| 2011 | 10 | 43 |
| 2012 | 13 | 43 |
| 2013 | 23 | 88 |
| 2014 | 43 | 85 |
| 2015 | 47 | 73 |
| 2016 | 49 | 102 |
| 2017 | 61 | 81 |
| 2018 | 62 | 74 |
| 2019 | 46 | 84 |
| 2020 | 36 | 74 |
| 2021 | 48 | 101 |
| 2022 | 53 | 98 |
| 2023 | 35 | 75 |
| 2024 | 49 | 68 |
| 2025 | 47 | 63 |
| 2026 | 27 | 56 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Prevention of viral transmission through feed6 Oct 2026US 12,751,931 B2Dsm IP Assets B.V.
- API stability in softgels29 Sep 2026US 12,746,206 B2R.P. Scherer Technologies, LLC
- Herbal bioactives based immunostimulant formulation for poultry birds and cattle and preparation thereof15 Sep 2026US 12,734,134 B2Edhas Technologies Inc.
- Methods and compositions for the treatment of corneal endothelium disorders8 Sep 2026US 12,728,118 B2The Schepens Eye Research Institute, Inc.
- Anti-aging composition with mTOR inhibitor for humans and other mammals1 Sep 2026US 12,721,822 B2
- Composition comprising particles containing reduced coenzyme q108 Oct 2026US 2026/0306424 A1Kaneka Corporation
- Reduced coenzyme q10 composition and production method for the same1 Oct 2026US 2026/0297008 A1Kaneka Corporation
- Animal models, screening methods, and treatment methods for intraocular diseases or disorders24 Sep 2026US 2026/0283123 A1Smilebiotek Zhuhai Limited
- Adipocyte growth inhibitor24 Sep 2026US 2026/0283977 A1Watanabe Oyster Laboratory Co., Ltd.
- Cleavable polymer drug conjugates24 Sep 2026US 2026/0284196 A1Rs Arastirma Egitim Danismanlik Ilac Sanayi Ticaret Anonim Sirketi
Most cited
By later US patents
- Delivery system for an oral care substance using a strip of material having low flexural stiffness139US 6,096,328 AThe Procter & Gamble Company · 2000
- Antimicrobial composition113US 6,022,551 AEthicon, Inc. · 2000
- Treatment of newborn jaundice100US 5,589,504 AAlbert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University · 1996
- Topical treatment and composition90US 4,661,524 ABeecham Group Limited · 1987
- Antiestrogens and their use in treatment of menopause and osteoporosis90US 4,894,373 ABCM Technologies · 1990